share_log

AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), Inline, Sales $40.000K Down From $49.000K YoY

Benzinga ·  May 16 18:54
AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), Inline, Sales $40.000K Down From $49.000K YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment